Merck's Welireg combo fails in first-line kidney cancer
THE SO WHAT
Welireg’s failure to improve first-line kidney cancer outcomes alongside Keytruda is a reminder that combo bets are not automatic value multipliers. For biotech portfolios, this is a nudge to reweight away from “add-on to blockbuster” stories toward differentiated mechanisms with standalone paths.
READ THE SOURCE
MORE FROM THE WIRE
Deep & Emerging Tech'The evidence is starting to mount': physicists at the LHC have found a possible 'anomaly' that could unlock 'a new understanding of how the universe works' — and 'charming penguins' may hold the key to whether the Standard Model is out of date
A four-sigma anomaly at the LHC is a reminder that the physics stack we build all our models on is still under negotiation. If this holds, expect a long tail of recalibration in simulation-heavy fields — from materials to chip design — not an overnight rewrite of reality.
Deep & Emerging TechIran alleges systematic sabotage of US-made networking infrastructure mid-conflict — hardware shut down and rebooted despite internet blackout
Allegations that foreign-made networking gear was remotely disrupted mid-conflict put supply-chain trust and firmware provenance at the center of national security. If you operate critical infrastructure anywhere, treat vendor hardware as a potential policy surface, not a neutral box.
Deep & Emerging TechWatch a Guy Fabricate Functioning Micron-Scale RAM Cells in His Garden Shed
A hobbyist building micron-scale RAM in a shed is a reminder that fabrication know-how is leaking out of cleanrooms into the wild. IP and export control strategies that assume advanced hardware is only made in tier-1 fabs are already outdated.
Deep & Emerging TechChina’s Tech Grip Threatens India’s Ambitions
India’s manufacturing push runs straight into China’s control of semis and batteries — the bottleneck isn’t labor, it’s upstream tech dependency. If you’re betting on India as an alternative supply base, model your exposure to Chinese components explicitly, not as a footnote.